Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-04

Clinical Trial Update: Post-operative or Early Salvage XRT and ADT for High Risk PCa [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating post-operative or early salvage radiotherapy with androgen deprivation therapy for high-risk prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED